Therapeutic Specialties Archives

On-Demand Webinar

Using Quantitative Systems Pharmacology (QSP) Modeling for Oncology Dose Optimization

The FDA’s Project Optimus initiative aims to reform dose optimization and selection for oncology therapies…

CertaraAugust 19, 2024

Case Study

Optimizing Clinical Development: Saving Time and Costs

Strategic mechanistic modeling solutions help an immunoncology biotech accelerate their clinical development of novel therapeutics.

CertaraAugust 16, 2024

Case Study

Medicines that matter: Biohaven’s Nurtec™ drug development journey

In February 2020, Biohaven Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) approved…

CertaraAugust 15, 2024

Case Study

Model-Informed Confidence in Oncology Dose Selection

Discover an oncology-focused company that gained confidence in their dose selection for an AML trial…

CertaraAugust 9, 2024

Video

Certara’s MIDD Oncology Capabilities

Improve Oncology Study Decisions with Certara's MIDD Team Transcript: The pace of oncology drug…

CertaraAugust 7, 2024

Publication

Dosing Strategies and Quantitative Clinical Pharmacology for Bispecific T-Cell Engagers Development in Oncology

CertaraJuly 23, 2024

Case Study

Systems Modeling Delivers Efficiencies and Savings in Clinical Development

Discover how an IO-focused company developing immunotherapies applied QSP modeling solutions for cost-effective clinical development.…

CertaraJuly 12, 2024

Press Coverage

Accelerating the Progress of Kinase Inhibitors in Oncology

The potential of PBPK modeling in answering key questions around these drugs. Hannah Jones, PhDMasoud…

CertaraMay 20, 2024

Blog

How to Navigate the FDA Landscape for an Orphan Drug

Rare diseases are a public health priority. FDA has launched several programs and a final…

CertaraFebruary 21, 2024

Publication

Incorporating Pragmatic Elements in Study Designs to Enhance Oncology Randomized Clinical Trials

A FRIENDS OF CANCER RESEARCH WHITE PAPER The article explores the complex landscape of determining…

CertaraDecember 19, 2023

Therapeutic Specialties

Using Quantitative Systems Pharmacology (QSP) Modeling for Oncology Dose Optimization

Optimizing Clinical Development: Saving Time and Costs

Medicines that matter: Biohaven’s Nurtec™ drug development journey

Model-Informed Confidence in Oncology Dose Selection

Certara’s MIDD Oncology Capabilities

Dosing Strategies and Quantitative Clinical Pharmacology for Bispecific T-Cell Engagers Development in Oncology

Systems Modeling Delivers Efficiencies and Savings in Clinical Development

Accelerating the Progress of Kinase Inhibitors in Oncology

How to Navigate the FDA Landscape for an Orphan Drug

Incorporating Pragmatic Elements in Study Designs to Enhance Oncology Randomized Clinical Trials

Newsletter sign up

Quick links

Solutions

Contact